AI Cyber Fears Ignite CrowdStrike Rally as July Accumulation Pays Off

‼️ 🧠 BREAKING: AI leaders’ warnings about frontier-model risks have renewed focus on AI-enabled cyber threats—from automated phishing to faster vulnerability exploitation. CrowdStrike is a high-beta way to play this theme, given Falcon’s cloud-native endpoint, identity, SIEM, and AI-security capabilities. We began accumulating CRWD in July.

AstraZeneca Deepens China Bet With New Asthma and Cancer Drug Deals

‼️ AstraZeneca has teamed with Chinese innovators on a range of medicines. It recently licensed an inhaled drug for asthma and chronic obstructive pulmonary disease that’s code-named TQC3721, from Sino BioPharmaceutical , as well as the oral targeted cancer drug Zegfrovy from Dizal Pharmaceutical . It is developing oral cancer drug Orpathys, with Hutchmed .